Partial agonist activity of carteolol on atypical β-adrenoceptors in the guinea pig duodenum
Introduction
Carteolol induces relaxation and behaves as a β-adrenoceptor partial agonist in the guinea pig taenia caecum (Takayanagi and Koike, 1983). Carteolol is generally accepted as a partial β1-/β2-adrenoceptor agonist and exhibits both stimulatory and inhibitory effects (Lipworth and Grove, 1997). Moreover, we showed that β2- and β3-adrenoceptors were involved in the β-adrenoceptor-mediated relaxation of the guinea pig taenia caecum Koike et al., 1994, Koike et al., 1995a, Koike et al., 1995b and that carteolol did not act as a β3-adrenoceptor agonist in the guinea pig taenia caecum (Koike et al., 1996).
However, Zhao et al. (1998) demonstrated that carteolol, described earlier as a partial agonist on β1- and β2-adrenoceptors, also possesses β3-adrenoceptor partial agonist properties on brown fat cells from mouse, rat and hamster. These facts suggest that carteolol-stimulated thermogenesis is mediated by β3-adrenoceptors in brown adipose tissue, but that carteolol-induced relaxation is mediated by β2-adrenoceptors in the taenia caecum. However, it remains possible that there are species differences in β3-adrenoceptors that β3-adrenoceptors of the guinea pig taenia caecum cannot recognize carteolol.
Recently, we have suggested that atypical β-adrenoceptors were involved in mediating the relaxant response of the guinea pig duodenum (Horinouchi and Koike, 1999a). We also showed that the relaxations in response to catecholamines (isoprenaline, noradrenaline and adrenaline), to a selective β3-adrenoceptor agonist, (R*,R*)-(±)-4-[2-[(2-(3-chlorophenyl)-2-hydroxyethyl)amino]propyl]phenoxyacetic acid sodium salt (BRL37344), and to a non-conventional partial β3-adrenoceptor agonist, [4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H-benzimidazol-2-one] hydrochloride (CGP12177A), were competitively antagonized by a non-selective β-adrenoceptor antagonist, bupranolol (Horinouchi and Koike, 1999a), although at a concentration much higher than that necessary for the blockade of β1- or β2-adrenoceptors (Kaumann, 1989).
Therefore, we attempted to clarify whether carteolol acts as a β3-adrenoceptor partial agonist at atypical β-adrenoceptors in the guinea pig duodenum by using catecholamines (isoprenaline, noradrenaline and adrenaline), BRL37344, CGP12177A and bupranolol.
Section snippets
Mechanical responses
Male Hartley guinea pigs weighing 300–500 g were killed by cervical dislocation and the entire duodenum was rapidly isolated and placed in oxygenated (a mixture of 95% O2 and 5% CO2) Ringer–Locke solution of the following composition (in mM): NaCl, 154; KCl, 5.6; CaCl2, 2.2; MgCl2, 2.1; NaHCO3, 5.9; and glucose, 2.8. The intraluminal contents were flushed out with Ringer–Locke solution and the connective tissue was dissected away. The outer layer of duodenum containing longitudinal smooth
Agonistic effect of carteolol
In the absence of propranolol, carteolol relaxed the histamine-induced tone in the guinea pig duodenum, with a pD2 value of 4.85±0.03 and an intrinsic activity of 0.96±0.03 (Fig. 1). The relaxant response to carteolol was insensitive to propranolol (1 μM; Fig. 1). The pD2 value and the intrinsic activity in the presence of propranolol were 4.90±0.01 and 0.93±0.03, respectively (Fig. 1).
Effect of bupranolol on relaxation to carteolol
In the presence of propranolol (1 μM) to block typical β-adrenoceptors, bupranolol (30 μM) antagonized the
Discussion
In the present study, partial agonist effects of carteolol on β-adrenoceptors mediating relaxation in the guinea pig duodenum have been examined. Carteolol induced concentration-dependent relaxation of histamine-precontracted guinea pig duodenum. However, the classical β-adrenoceptor antagonist, propranolol (1 μM), failed to produce significant shifts of the carteolol concentration–response curve, indicating the possible involvement of atypical β-adrenoceptors. Strong evidence for atypical
Acknowledgements
Kaken Pharmaceutical (Tokyo, Japan) is thanked for the gift of bupranolol hydrochloride.
References (20)
Pharmacological criteria for the detection of β3-adrenoceptors. Is it time for a reappraisal?
Trends Pharmacol. Sci.
(1997)- et al.
Characterization of atypical β-adrenoceptors in the guinea pig duodenum
Eur. J. Pharmacol.
(1999) Is there a third heart β-adrenoceptor?
Trends Pharmacol. Sci.
(1989)- et al.
Relationship between intrinsic activity of β-adrenoceptor agonist and amount of spare receptors in guinea pig taenia caecum
Jpn. J. Pharmacol.
(1983) - et al.
Involvement of β3-adrenoceptor in the relaxation response in guinea pig taenia caecum
Jpn. J. Pharmacol.
(1994) - et al.
Signal transduction pathway involved in β3-adrenoceptor-mediated relaxation in guinea pig taenia caecum
Jpn. J. Pharmacol.
(1995) - et al.
Possible mechanisms of β-adrenoceptor-mediated relaxation induced by noradrenaline in guinea pig taenia caecum
Eur. J. Pharmacol.
(1995) - et al.
A trial for kinetic evaluation of the antagonistic potency of several beta-antagonists on presynaptic beta-adrenoceptors
Jpn. J. Pharmacol.
(1987) - et al.
Pharmacological properties of β3-adrenoceptors. Receptor and drug classification: the need for reappraisal of pharmacological tools and expression system
Trends Pharmacol. Sci.
(1997) - et al.
The β3-adrenoceptor constitutes indeed a versatile receptor
Trends Pharmacol. Sci.
(1997)
Cited by (6)
Agonistic activity of SR59230A at atypical β-adrenoceptors in guinea pig gastric fundus and duodenum
2001, European Journal of PharmacologyFunctional properties of atypical β-adrenoceptors on the guinea pig duodenum
2001, European Journal of Pharmacologyβ<inf>2</inf>-Adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: An in vivo study
2004, Naunyn-Schmiedeberg's Archives of PharmacologyPartial agonistic activity of labetalol, the arylethanolamine, on β<inf>3</inf>-adrenoceptors in the guinea-pig gastric fundus
2002, Autonomic and Autacoid PharmacologyFurther characterization of β<inf>3</inf>-adrenoceptors in the guinea pig gastric fundus: Stereoselectivity, β-adrenoceptor alkylation, and structure-activity relationship
2001, Canadian Journal of Physiology and Pharmacology